Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure

Drug News Perspect. 2009 Jun;22(5):267-73. doi: 10.1358/dnp.2009.22.5.1378643.

Abstract

The use of natriuretic peptide testing has expanded considerably over the recent years. Thanks to clinical trials that have demonstrated significant benefits associated with testing for B-type natriuretic peptide (BNP) and its amino-terminal pro-peptide (NTproBNP), testing for these peptides is now ubiquitous in modern medicine. This review will focus on the use of NTproBNP in clinical medicine, with a discussion of the biologic significance of NT-proBNP, its proven present uses and potential future applications.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood
  • Cardiovascular Agents / therapeutic use
  • Clinical Trials as Topic
  • Heart Failure / diagnosis*
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology
  • Humans
  • Natriuretic Peptide, Brain / blood*
  • Peptide Fragments / blood*
  • Prognosis

Substances

  • Biomarkers
  • Cardiovascular Agents
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain